Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Juvenile Myelomonocytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Looking for participantsNCT05488548
What this trial is testing

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Castrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more
Epigenetix, Inc. 75
Not applicableStudy completedNCT03526666
What this trial is testing

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
Van Andel Research Institute 50
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07249346
What this trial is testing

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
Hannah Choe, MD 124
Not applicableUnknownNCT03687463
What this trial is testing

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 6
Early research (Phase 1)Study completedNCT00022451
What this trial is testing

Tipifarnib in Treating Young Patients With Refractory Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT01192945
What this trial is testing

Non-interventional Study With Azacitidin (Vidaza®)

Who this might be right for
MDSAMLCMMOL
iOMEDICO AG 150
Early research (Phase 1)Study completedNCT00004047
What this trial is testing

Chemotherapy in Treating Patients Who Have Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Daiichi Sankyo
Testing effectiveness (Phase 2)Ended earlyNCT00997243
What this trial is testing

Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Alison Walker 7
Testing effectiveness (Phase 2)Looking for participantsNCT07033598
What this trial is testing

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Who this might be right for
Leukemia, Myelomonocytic, Chronic
Theradex 66
Testing effectiveness (Phase 2)Study completedNCT00079313
What this trial is testing

Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelogenous Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 7
Early research (Phase 1)Study completedNCT00012376
What this trial is testing

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+15 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00381550
What this trial is testing

3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT06543381
What this trial is testing

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 15
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Early research (Phase 1)Study completedNCT00004245
What this trial is testing

Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Not applicableLooking for participantsNCT07512882
What this trial is testing

Cohort of Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
LeukemiaMyelomonocytic Leukemia, Chronic
Gustave Roussy, Cancer Campus, Grand Paris 5,000
Early research (Phase 1)Ended earlyNCT00356928
What this trial is testing

Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Next Page